Data from multiple sources - Curated by Marshall Pearce - Last updated 06 June 2017

Latest news articles

Added 12 days ago Drug news

FDA approves sNDA for Alecensa in ALK+ metastatic non-small cell lung cancer.- Genentech.

Genentech announced that the FDA approved the supplemental New Drug Application for Alecensa (alectinib) for the treatment of people with...

Added 17 days ago Drug news

NICE recommends use of Opdivo in squamous non-small-cell lung cancer.- BMS.

Opdivo (nivolumab), from BMS, is recommended by NICE for use within the Cancer Drugs Fund as an option for treating...

Added 30 days ago Drug news

Positive results from Keynote 024 trial for Keytruda for NSCLC.- Merck Inc.

Merck announced the presentation of updated overall survival (OS) findings, a secondary endpoint, from the phase III KEYNOTE-024 trial evaluating...

Search all news articles for Cancer of bronchus or lung
 

Learning Zones

An epgonline.org Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.

Transplantation

Transplantation

See information on best practice in solid organ transplantation, and expert discussions on related hot topics.

Oral Anticoagulation Reversal

Oral Anticoagulation Reversal

Experts discuss the use of non-vitamin K oral anticoagulants in the treatment and prevention of stroke, deep vein thrombosis and pulmonary embolism in atrial fibrillation patients.

Load more

Guidelines

Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

These updated guidelines on early and locally advanced non-small-cell lung cancer focus on treatment recommendations including follow-up and survivorship.

Added 4 years ago

British Thoracic Society guidelines for the investigation and management of pulmonary nodules

The detection of pulmonary nodules is common. In populations undergoing CT screening and at high risk of lung cancer, nodules are...

Added 2 years ago

Treatment of dyspnoea in advanced cancer patients: ESMO Clinical Practice Guidelines

Dyspnoea is described as difficult or laboured breathing and is a frequent symptom in advanced cancer patients, with the highest...

Added 2 years ago

Search all guidelines for Cancer of bronchus or lung
 

Journal articles

A molecular and preclinical comparison of the PD-1-targeted T-cell checkpoint inhibitors nivolumab and pembrolizumab.

T-cell checkpoint inhibition has a profound impact on cancer care and the programmed cell death protein 1 (PD-1)-targeted antibodies nivolumab and pembrolizumab have been two of the lead molecules of this therapeutic revolution.

Added 1 month ago

Pembrolizumab in the treatment of metastatic non-small cell lung cancer: a review of current evidence.

Immune checkpoint inhibitors (ICPIs) are considered one of the most important breakthroughs in cancer treatment of the past decade; notably, different studies of programmed cell death protein 1 (PD-1)...

Added 1 month ago

Focus on Nintedanib in NSCLC and Other Tumors.

Nintedanib is a new triple angiokinase inhibitor that potently blocks the proangiogenic pathways mediated by vascular endothelial growth factor receptors, platelet-derived growth factor receptors, and fibroblast growth factor receptors.

Added 1 month ago

Search all journal articles for Cancer of bronchus or lung
 

Clinical trials

Sublobar Resection Versus Lobectomy for cT1N0M0 Non-small-cell Lung Cancer

The incidence rate of ground-glass opacity (GGO) has been increasing these years. A great number of retrospective studies suggested that sublobar resection was better for some GGO patients.

Added 9 days ago

A Study of Atezolizumab Compared With Docetaxel in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Failed Platinum-Containing Therapy (OAK)

This global, multicenter, open-label, randomized, controlled study will evaluate the efficacy and safety of atezolizumab (an anti-programmed death−ligand 1 [anti-PD-L1] antibody) compared with docetaxel...

Added 1 month ago

Optimal Extent of Pulmonary Resection in Clinical Stage IA Non-Small Cell Lung Cancer (OREX-IA)

The purpose of this study is to determine the outcome of participants with clinical stage IA NSCLC treated by 3 types of surgical resection (wide wedge resection, segmentectomy, or lobectomy) according to the institutional decision-making algorithm

Added 9 days ago

Search all clinical trials for Cancer of bronchus or lung
 
Fiona Holland

Fiona worked in the fitness and wellness industry in the US for 13 years, supporting behaviour change in a variety of settings. Fiona’s research interests lie broadly within health and wellbeing. She is particularly interested in qualitative methodologies in the areas of body image ... Read more

What to say and do when someone has cancer

Ahead of World Cancer Day on Saturday (February 4), Fiona Holland, Psychology Lecturer, discusses what to say and what not to say to someone with cancer.

CME

Carcinoma of unknown primary origin: diagnosis and management: putting NICE guidelines into practice

Accrediting body
Union of European Medical Specialists (via European Accreditation Council for CME)
Credits available
1
Registration required
1
Subscription fee
90

Non-small cell lung cancer: clinical review

Accrediting body
MIMS Learning - Monthly Index of Medical Specialities
Credits available
2
Registration required
1
Subscription fee
0

Lung cancer: clinical review

Accrediting body
MIMS Learning - Monthly Index of Medical Specialities
Credits available
1
Registration required
1
Subscription fee
0
Search all CME for Cancer of bronchus or lung